Furthermore, results from xenograft experiments showed that RO-3306 inhibited tumor growth and increased sensitivity to cisplatin, which was also largely abrogated by the deficiency of VHL (Fig. 7G, H and Supplementary Fig. 8J). Here, VHL is linked to neoplasm.